NS Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,764
| Closed | -$2.78M | – | 73 |
|
|
2025
Q1 | $2.78M | Sell |
16,764
-61,179
| -78% | -$9.57M | 0.12% | 66 |
|
|
2024
Q4 | $11.3M | Sell |
77,943
-3,012
| -4% | -$467K | 0.47% | 57 |
|
|
2024
Q3 | $13.1M | Sell |
80,955
-4,393
| -5% | -$700K | 0.55% | 56 |
|
|
2024
Q2 | $12.5M | Sell |
85,348
-3,991
| -4% | -$594K | 0.57% | 54 |
|
|
2024
Q1 | $14.1M | Sell |
89,339
-4,629
| -5% | -$737K | 0.65% | 54 |
|
|
2023
Q4 | $14.7M | Sell |
93,968
-25,576
| -21% | -$3.92M | 0.72% | 53 |
|
|
2023
Q3 | $18.6M | Sell |
119,544
-36,105
| -23% | -$5.96M | 1% | 41 |
|
|
2023
Q2 | $25.8M | Buy |
155,649
+17,845
| +13% | +$2.88M | 1.36% | 25 |
|
|
2023
Q1 | $21.4M | Sell |
137,804
-423
| -0.3% | -$68.3K | 1.2% | 36 |
|
|
2022
Q4 | $24.4M | Sell |
138,227
-954
| -0.7% | -$165K | 1.47% | 21 |
|
|
2022
Q3 | $22.7M | Buy |
139,181
+3,227
| +2% | +$546K | 1.48% | 21 |
|
|
2022
Q2 | $24.1M | Buy |
135,954
+1,814
| +1% | +$323K | 1.47% | 24 |
|
|
2022
Q1 | $23.8M | Sell |
134,140
-8,600
| -6% | -$1.46M | 1.27% | 27 |
|
|
2021
Q4 | $24.4M | Sell |
142,740
-6,457
| -4% | -$1.06M | 1.14% | 36 |
|
|
2021
Q3 | $24.1M | Sell |
149,197
-12,416
| -8% | -$2.12M | 1.23% | 31 |
|
|
2021
Q2 | $26.6M | Sell |
161,613
-6,392
| -4% | -$1.06M | 1.4% | 24 |
|
|
2021
Q1 | $27.6M | Sell |
168,005
-13,869
| -8% | -$2.24M | 1.6% | 19 |
|
|
2020
Q4 | $28.6M | Sell |
181,874
-1,283
| -0.7% | -$189K | 1.67% | 21 |
|
|
2020
Q3 | $27.3M | Buy |
183,157
+1,873
| +1% | +$277K | 1.8% | 20 |
|
|
2020
Q2 | $25.5M | Sell |
181,284
-799
| -0.4% | -$116K | 1.89% | 16 |
|
|
2020
Q1 | $23.9M | Buy |
182,083
+4,864
| +3% | +$690K | 2.22% | 11 |
|
|
2019
Q4 | $25.9M | Buy |
177,219
+6,483
| +4% | +$879K | 2.06% | 13 |
|
|
2019
Q3 | $22.1M | Sell |
170,736
-38,497
| -18% | -$5.07M | 1.99% | 17 |
|
|
2019
Q2 | $29.1M | Buy |
209,233
+1,253
| +0.6% | +$173K | 2.68% | 4 |
|
|
2019
Q1 | $29.1M | Buy |
207,980
+301
| +0.1% | +$40.3K | 2.69% | 4 |
|
|
2018
Q4 | $26.8M | Buy |
207,679
+24,075
| +13% | +$3.36M | 2.87% | 5 |
|
|
2018
Q3 | $25.4M | Buy |
183,604
+937
| +0.5% | +$125K | 2.42% | 6 |
|
|
2018
Q2 | $22.2M | Sell |
182,667
-880
| -0.5% | -$110K | 2.27% | 6 |
|
|
2018
Q1 | $23.5M | Buy |
183,547
+2,723
| +2% | +$368K | 2.51% | 5 |
|
|
2017
Q4 | $25.3M | Buy |
180,824
+9,934
| +6% | +$1.38M | 2.77% | 5 |
|
|
2017
Q3 | $22.2M | Buy |
170,890
+12,817
| +8% | +$1.7M | 2.65% | 5 |
|
|
2017
Q2 | $20.9M | Buy |
158,073
+75,826
| +92% | +$9.67M | 2.74% | 4 |
|
|
2017
Q1 | $10.2M | Buy |
82,247
+33,962
| +70% | +$4.06M | 1.47% | 18 |
|
|
2016
Q4 | $5.56M | Sell |
48,285
-5,487
| -10% | -$634K | 0.87% | 48 |
|
|
2016
Q3 | $6.35M | Sell |
53,772
-147
| -0.3% | -$17.8K | 1.04% | 40 |
|
|
2016
Q2 | $6.54M | Sell |
53,919
-3,132
| -5% | -$356K | 1.12% | 36 |
|
|
2016
Q1 | $6.17M | Buy |
57,051
+11,961
| +27% | +$1.24M | 1.11% | 31 |
|
|
2015
Q4 | $4.63M | Buy |
45,090
+30,227
| +203% | +$3.04M | 0.83% | 55 |
|
|
2015
Q3 | $1.39M | Sell |
14,863
-1,900
| -11% | -$184K | 0.24% | 83 |
|
|
2015
Q2 | $1.63M | Buy |
+16,763
| New | +$1.68M | 0.26% | 82 |
|
Other funds holding JNJ
NS Partners's JNJ Position: Q2 2025 in Review
NS Partners sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 16,764 shares — an estimated $2.78M sold.
NS Partners first reported a position in JNJ in Q2 2015 and held it in 40 quarters. The position peaked at $29.1M in Q2 2019. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.
- NS Partners reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
- NS Partners sold 16,764 Johnson & Johnson shares in Q2 2025, an estimated $2.78M.
- NS Partners first reported a position in Johnson & Johnson in Q2 2015 and held it in 40 quarters.
- NS Partners's Johnson & Johnson position peaked at $29.1M in Q2 2019.
- 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.
Based on NS Partners's 13F filing for Q2 2025, filed 7 Aug 2025.